Cargando…

An Analysis of Patient-Reported Recovery Outcomes of Topical Tripeptide/Hexapeptide Formulations Utilized in a Prospective Randomized Double-Blind Split Neck and Body Study

BACKGROUND: Physicians strive to improve the postsurgical experience and optimize patient-reported recovery outcome measures (PROMs) following elective cosmetic surgical procedures. Our previous pilot feasibility study demonstrated that twice daily postoperative topical body treatment with tripeptid...

Descripción completa

Detalles Bibliográficos
Autores principales: Casas, Laurie A, Bell, Michaela, Claytor, Brannon, Ziegler, Mary E, Widgerow, Alan D
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7984834/
https://www.ncbi.nlm.nih.gov/pubmed/33791673
http://dx.doi.org/10.1093/asjof/ojaa052
_version_ 1783668118704357376
author Casas, Laurie A
Bell, Michaela
Claytor, Brannon
Ziegler, Mary E
Widgerow, Alan D
author_facet Casas, Laurie A
Bell, Michaela
Claytor, Brannon
Ziegler, Mary E
Widgerow, Alan D
author_sort Casas, Laurie A
collection PubMed
description BACKGROUND: Physicians strive to improve the postsurgical experience and optimize patient-reported recovery outcome measures (PROMs) following elective cosmetic surgical procedures. Our previous pilot feasibility study demonstrated that twice daily postoperative topical body treatment with tripeptide and hexapeptide (TransFORM Body Treatment with TriHex Technology [TFB, Alastin Skincare, Inc., Carlsbad, CA]) reduced PROMs of swelling, induration, soft tissue fibrosis, and pain as well as improved visible and palpable skin quality. OBJECTIVES: Evaluate whether adding a tripeptide/hexapeptide anhydrous gel (Regenerating Skin Nectar with TriHex Technology [RSN, Alastin Skincare, Inc., Carlsbad, CA]) pre- and post-procedure to the existing postsurgical regimen of TFB significantly improves 6 PROMs in patients undergoing neck and body contouring cosmetic surgical procedures. METHODS: Ten female patients underwent 15 neck and body contouring procedures and were blindly randomized to 1 of 2 topical treatment protocols (1 [TFB] and 2 [RSN/TFB]) pre- and post-procedure. Patient-reported scores of 5 skin parameters (skin discoloration, ecchymosis, edema, induration, and subcutaneous fibrous banding) and pain scores using the Visual Analog Scale were collected at 8 intervals for 12 weeks post-procedure. RESULTS: The treatment side that used both topicals showed significantly reduced scores of edema, induration, and subcutaneous fibrous banding compared with the side that only used 1 topical, on days 5–7 and 10–14 (P < 0.05). All patients observed slower soft tissue recovery on the side that was treated with TFB alone and opted to break the code and use both topical treatments. CONCLUSIONS: Patients had statistically significant improved patient-reported measures of skin edema, skin induration, and subcutaneous banding on the operated side that used both topicals. LEVEL OF EVIDENCE: 2: [Image: see text]
format Online
Article
Text
id pubmed-7984834
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-79848342021-03-30 An Analysis of Patient-Reported Recovery Outcomes of Topical Tripeptide/Hexapeptide Formulations Utilized in a Prospective Randomized Double-Blind Split Neck and Body Study Casas, Laurie A Bell, Michaela Claytor, Brannon Ziegler, Mary E Widgerow, Alan D Aesthet Surg J Open Forum Body Contouring BACKGROUND: Physicians strive to improve the postsurgical experience and optimize patient-reported recovery outcome measures (PROMs) following elective cosmetic surgical procedures. Our previous pilot feasibility study demonstrated that twice daily postoperative topical body treatment with tripeptide and hexapeptide (TransFORM Body Treatment with TriHex Technology [TFB, Alastin Skincare, Inc., Carlsbad, CA]) reduced PROMs of swelling, induration, soft tissue fibrosis, and pain as well as improved visible and palpable skin quality. OBJECTIVES: Evaluate whether adding a tripeptide/hexapeptide anhydrous gel (Regenerating Skin Nectar with TriHex Technology [RSN, Alastin Skincare, Inc., Carlsbad, CA]) pre- and post-procedure to the existing postsurgical regimen of TFB significantly improves 6 PROMs in patients undergoing neck and body contouring cosmetic surgical procedures. METHODS: Ten female patients underwent 15 neck and body contouring procedures and were blindly randomized to 1 of 2 topical treatment protocols (1 [TFB] and 2 [RSN/TFB]) pre- and post-procedure. Patient-reported scores of 5 skin parameters (skin discoloration, ecchymosis, edema, induration, and subcutaneous fibrous banding) and pain scores using the Visual Analog Scale were collected at 8 intervals for 12 weeks post-procedure. RESULTS: The treatment side that used both topicals showed significantly reduced scores of edema, induration, and subcutaneous fibrous banding compared with the side that only used 1 topical, on days 5–7 and 10–14 (P < 0.05). All patients observed slower soft tissue recovery on the side that was treated with TFB alone and opted to break the code and use both topical treatments. CONCLUSIONS: Patients had statistically significant improved patient-reported measures of skin edema, skin induration, and subcutaneous banding on the operated side that used both topicals. LEVEL OF EVIDENCE: 2: [Image: see text] Oxford University Press 2020-11-18 /pmc/articles/PMC7984834/ /pubmed/33791673 http://dx.doi.org/10.1093/asjof/ojaa052 Text en © 2020 The Aesthetic Society. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Body Contouring
Casas, Laurie A
Bell, Michaela
Claytor, Brannon
Ziegler, Mary E
Widgerow, Alan D
An Analysis of Patient-Reported Recovery Outcomes of Topical Tripeptide/Hexapeptide Formulations Utilized in a Prospective Randomized Double-Blind Split Neck and Body Study
title An Analysis of Patient-Reported Recovery Outcomes of Topical Tripeptide/Hexapeptide Formulations Utilized in a Prospective Randomized Double-Blind Split Neck and Body Study
title_full An Analysis of Patient-Reported Recovery Outcomes of Topical Tripeptide/Hexapeptide Formulations Utilized in a Prospective Randomized Double-Blind Split Neck and Body Study
title_fullStr An Analysis of Patient-Reported Recovery Outcomes of Topical Tripeptide/Hexapeptide Formulations Utilized in a Prospective Randomized Double-Blind Split Neck and Body Study
title_full_unstemmed An Analysis of Patient-Reported Recovery Outcomes of Topical Tripeptide/Hexapeptide Formulations Utilized in a Prospective Randomized Double-Blind Split Neck and Body Study
title_short An Analysis of Patient-Reported Recovery Outcomes of Topical Tripeptide/Hexapeptide Formulations Utilized in a Prospective Randomized Double-Blind Split Neck and Body Study
title_sort analysis of patient-reported recovery outcomes of topical tripeptide/hexapeptide formulations utilized in a prospective randomized double-blind split neck and body study
topic Body Contouring
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7984834/
https://www.ncbi.nlm.nih.gov/pubmed/33791673
http://dx.doi.org/10.1093/asjof/ojaa052
work_keys_str_mv AT casaslauriea ananalysisofpatientreportedrecoveryoutcomesoftopicaltripeptidehexapeptideformulationsutilizedinaprospectiverandomizeddoubleblindsplitneckandbodystudy
AT bellmichaela ananalysisofpatientreportedrecoveryoutcomesoftopicaltripeptidehexapeptideformulationsutilizedinaprospectiverandomizeddoubleblindsplitneckandbodystudy
AT claytorbrannon ananalysisofpatientreportedrecoveryoutcomesoftopicaltripeptidehexapeptideformulationsutilizedinaprospectiverandomizeddoubleblindsplitneckandbodystudy
AT zieglermarye ananalysisofpatientreportedrecoveryoutcomesoftopicaltripeptidehexapeptideformulationsutilizedinaprospectiverandomizeddoubleblindsplitneckandbodystudy
AT widgerowaland ananalysisofpatientreportedrecoveryoutcomesoftopicaltripeptidehexapeptideformulationsutilizedinaprospectiverandomizeddoubleblindsplitneckandbodystudy
AT casaslauriea analysisofpatientreportedrecoveryoutcomesoftopicaltripeptidehexapeptideformulationsutilizedinaprospectiverandomizeddoubleblindsplitneckandbodystudy
AT bellmichaela analysisofpatientreportedrecoveryoutcomesoftopicaltripeptidehexapeptideformulationsutilizedinaprospectiverandomizeddoubleblindsplitneckandbodystudy
AT claytorbrannon analysisofpatientreportedrecoveryoutcomesoftopicaltripeptidehexapeptideformulationsutilizedinaprospectiverandomizeddoubleblindsplitneckandbodystudy
AT zieglermarye analysisofpatientreportedrecoveryoutcomesoftopicaltripeptidehexapeptideformulationsutilizedinaprospectiverandomizeddoubleblindsplitneckandbodystudy
AT widgerowaland analysisofpatientreportedrecoveryoutcomesoftopicaltripeptidehexapeptideformulationsutilizedinaprospectiverandomizeddoubleblindsplitneckandbodystudy